Soleus Capital Management’s NEVRO CORP. NVRO Stock Holding History

Soleus Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-72,000	Closed	-$3.35M	–	93
2022 Q3	$3.35M	Buy	+72,000	New	+$3.34M	0.46%	50
2021 Q1	–	Sell	-9,589	Closed	-$1.66M	–	84
2020 Q4	$1.66M	Sell	9,589 -2,337	-20%	-$378K	0.22%	43
2020 Q3	$1.66M	Sell	11,926 -6,874	-37%	-$918K	0.88%	35
2020 Q2	$2.25M	Buy	+18,800	New	+$2.23M	1.28%	27
2020 Q1	–	Sell	-8,246	Closed	-$969K	–	61
2019 Q4	$969K	Buy	+8,246	New	+$817K	0.93%	29

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Soleus Capital Management's NVRO Position: Q4 2022 in Review

Soleus Capital Management sold out of NEVRO CORP. (NVRO) in Q4 2022, closing a stake of 72,000 shares — an estimated $3.35M sold.

Soleus Capital Management first reported a position in NVRO in Q4 2019 and held it in 5 quarters. The position peaked at $3.35M in Q3 2022. 170 funds tracked by Wall St. Rank hold NVRO as of Q4 2022.

Soleus Capital Management reported no remaining NEVRO CORP. position as of Q4 2022 after selling out during the quarter.
Soleus Capital Management sold 72,000 NEVRO CORP. shares in Q4 2022, an estimated $3.35M.
Soleus Capital Management first reported a position in NEVRO CORP. in Q4 2019 and held it in 5 quarters.
Soleus Capital Management's NEVRO CORP. position peaked at $3.35M in Q3 2022.
170 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2022.

Based on Soleus Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.